Affordable Access

Publisher Website

Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?

Authors
  • Chirumbolo, Salvatore1
  • 1 Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. , (Italy)
Type
Published Article
Journal
Journal of Medical Virology
Publisher
Wiley (John Wiley & Sons)
Publication Date
Jul 01, 2021
Volume
93
Issue
7
Pages
4049–4053
Identifiers
DOI: 10.1002/jmv.26922
PMID: 33666240
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Coronavirus disease 2019 (COVID-19) vaccination campaign in Italy has started with a huge perplexity about vaccine efficacy, vaccine-borne adverse effects and vaccine clinical trial studies. In this commentary I tried to elucidate these issues, which represent a fundamental topic to be thoroughly addressed in COVID-19 pandemic. © 2021 Wiley Periodicals LLC.

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 12/22/2023 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/33666240
Report this publication

Statistics

Seen <100 times